Fiona Barry

Journo. Editor-in-Chief, GlobalData
[email protected]
[email protected]

[Fiona Barry @FionaReporter]

Trump’s agency nominations have the pharma world divided. Are they a prescription for progress or side effects waiting to happen? Read more: https://t.co/UyizReChq9 #PharmaPolitics #Healthcare #FDA via @PharmaTechFocus @Healthcare_GD

[Fiona Barry @FionaReporter]

What's the next big challenge for cell and gene therapies? @alliancerm @IBcommsagency
https://t.co/69G5wBUYf2

[Fiona Barry @FionaReporter]

US Election: In close race, tiny Senate majority, not President, will hold power
https://t.co/44P1WPB1ez via @PharmaTechFocus #electionday2024 #KamalaHarris #DonaldTrump

[Fiona Barry @FionaReporter]

@CNBC The Chinese cities under shutdown are in Guangdong and Jilin provinces, suppliers of pharmaceuticals to the world: https://t.co/fPqrNvvrXs
https://t.co/RWltUdqgy5
#COVID19 #Shenzhen #shutdown #Pharmaceutical #supplychain

[Fiona Barry @FionaReporter]

LSD, MDMA, and magic mushrooms are showing success in human trials for conditions like depression, anxiety, and PTSD:

[Gibson Johns @gibsonoma]

Waiting on that episode of The Dropout about the Elizabeth Holmes verdict to drop like…

[Pharmaceutical Commerce @PharmaCommerce]

🗞️The #pharmaceutical industry will need to outsource even more #pharma #manufacturing to keep up with the speed of the developments surrounding Covid-19 #vaccines and drugs, says @PharmSource, a data and #analytics company.
➡️https://t.co/u6fOMkH8l5

#PharmaNews #Pharmaceuticals

[Fiona Barry @FionaReporter]

Latest report from @HorganQuentin

[Peter Shapiro @shapiropj]

.@FionaReporter a "more immediate stress on the viral vector supply chain is their use in some #COVID19 #vaccines, specifically recombinant vector vaccines. @AstraZeneca and @JNJNews vaccines" https://t.co/lPB0LJHR8I @ExpPharma

[Sharon Cartic @sharoncartic]

GlobalData Plc is hiring an Analyst, Pharmaceutical Business Fundamentals Databases (Ref VN493) in London, UK. If you are looking for an exciting opportunity within our Data & Analytics team please apply within #hiring #jobs #pharma #analyst #globaldataplc https://t.co/0QenhtVX7g

[Sharon Cartic @sharoncartic]

GlobalData Plc is hiring an Analyst, Drugs Database (Ref VN496) in London, UK. If you are looking for an exciting opportunity within our Data & Analytics team please apply within #hiring #jobs #pharma #analyst #globaldataplc https://t.co/0QenhtVX7g

[Fiona Barry @FionaReporter]

BREAKING: European Medicines Agency press conference declares #AstraZeneca COVID-19 vaccine safe, after investigating blood clots in small number of recipients #EMA #astrazenecavaccine #COVID19Vaccine

[Sharon Cartic @sharoncartic]

Former congressional leaders’ predictions about healthcare policy and legislation change under Biden’s administration https://t.co/KeWL5TWEAO via @PharmaTechFocus

[Fiona Barry @FionaReporter]

With so much (mis)information swirling about COVID-19 vaccines, I talked to @surfernan for her fantastic podcast @thecovaxfiles. What's going on with the supply chain? And how are mRNA vaccines different from "traditional" types?

[EU Medicines Agency @EMA_News]

Did you miss our press briefing yesterday on the Agency’s recommendation on the #COVID19vaccine developed by BioNTech/Pfizer? You can watch it on EMA’s YouTube channel: https://t.co/rfPVzSkFEh

[Michael F Ozaki MD @brontyman]

Moderna COVID-19 shots leave warehouses, widening U.S. immunization push - Reuters https://t.co/l4Y9q0UvVX

[THREAD @THREADresearch]

According to @PharmSource, the top reason for trial disruption is slow enrollment, causing delays in 49% of disrupted #ClinicalTrials: https://t.co/SOVP5gBxaH | #ClinicalResearch

[Fiona Barry @FionaReporter]

Flurry of manufacturing deals for billions of Covid-19 vaccine doses – while CDC and Trump at odds over production timeline. My comment piece for @PharmaTechFocus #VaccinesWork #covidupdates

[Louis Garguilo @Louis_Garguilo]

COVID-19 Vaccine Manufacturing Challenges Spark Surge In Outsourcing Deals https://t.co/Q41Vx9nOGI @FionaReporter

[The Herald @heraldscotland]

Test subjects could be exposed to the new coronavirus in controlled settings from January in a bid to speed up vaccine development, officials have confirmed. https://t.co/r3hWz3PduR